Aidoc, a New York-based provider of AI-enabled medical imaging solutions, has raised $150 million in a Series E financing round, bringing its total funding to over $500 million. The round was led by Growth Equity at Goldman Sachs Alternatives, with participation from General Catalyst, SoftBank Investment Advisors, and NVentures, the venture capital arm of NVIDIA.
The company develops AI tools designed to support radiology, cardiology, vascular, and neurovascular care teams. Its platform assists clinicians in identifying and triaging medical conditions through imaging data, while also offering care coordination software that facilitates communication across teams, particularly in time-sensitive cases such as stroke and cardiovascular events.
Proceeds from the Series E round will be directed toward expanding Aidoc’s global footprint, advancing its CARE foundation model, and increasing coverage across additional clinical indications. The company also plans to introduce new capabilities, including automated generation of imaging draft reports as part of broader clinical workflow automation.
Elad Walach, cofounder and CEO of Aidoc, said: “By 2030, every complex diagnostic decision should be supported by AI that enables earlier detection and reduces preventable error. We feel a deep responsibility to deploy CARE safely and at scale across health systems. This funding accelerates comprehensive disease coverage and advances end-to-end AI across CT and X-ray, spanning the full workflow, including pixel to draft report within two years.”
Aidoc has continued to expand its regulatory footprint alongside product development. In January, the company received FDA clearance for an AI triage tool integrating 14 indications into a unified workflow, enabling clinicians to prioritize a wide range of acute findings. The company also previously secured FDA clearance for its rib fracture triage solution, CADt AI, built on its CARE1 Foundation Model.
The latest raise follows a series of financing rounds, including $150 million in 2025, $30 million in 2023, $110 million in 2022, and $66 million in 2021. Aidoc has also attracted investment from major health systems such as Hartford HealthCare, Mercy, Sutter Health, and WellSpan Health.
The funding positions Aidoc to further develop end-to-end AI-driven imaging workflows while addressing growing demand for scalable clinical decision support tools.
Click here for the original news story.
